0001193125-12-493792.txt : 20121206 0001193125-12-493792.hdr.sgml : 20121206 20121206163939 ACCESSION NUMBER: 0001193125-12-493792 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20121206 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20121206 DATE AS OF CHANGE: 20121206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] IRS NUMBER: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 121247114 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129303011 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 d449371d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 6, 2012

 

 

CME GROUP INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-31553   36-4459170
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

20 South Wacker Drive, Chicago, Illinois 60606

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01. Other Events.

CME Group Inc. (the “Company”) is filing this Current Report on Form 8-K (this “Report”) to present (i) selected financial data for the fiscal years ended December 31, 2007, 2008, 2009, 2010 and 2011 reflecting, on a retrospective basis, the five-for-one split of the Company’s Class A common stock effected by way of a stock dividend to its Class A and Class B shareholders effective July 20, 2012 (the “Stock Split”) and (ii) unaudited statements of comprehensive income for the fiscal years ended December 31, 2009, 2010 and 2011 reflecting the retrospective application of Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income, as amended by FASB ASU No. 2011-12, Comprehensive Income (Topic 220): Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05, adopted by the Company effective January 1, 2012 and pursuant to which, beginning with its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2012, the Company began providing consolidated statements of comprehensive income. The Company’s adoption of the accounting standard in FASB ASU Nos. 2011-05 and No. 2011-12 resulted only in changes to presentation of the Company’s financial statements and does not change existing recognition and measurement requirements in the Company’s consolidated financial statements.

The selected financial data described above is included in Exhibit 99.1 to this Report and incorporated herein by reference, and the unaudited statements of comprehensive income described above are included in Exhibit 99.2 to this Report and incorporated herein by reference.

The information included in this Report is presented for informational purposes only in connection with the Stock Split and the adoption of the accounting standard described above and does not amend or restate the selected financial data or the audited consolidated financial statements of the Company and its subsidiaries that were included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011 filed with the SEC on February 28, 2012 (the “2011 Annual Report”). This Report does not reflect events or developments that occurred after February 28, 2012, and does not modify or update the disclosures in the 2011 Annual Report in any way, other than to illustrate the Stock Split and the adoption of the accounting standard as described above and set forth in Exhibits 99.1 and 99.2 hereto. The information in this Report should be read in conjunction with the 2011 Annual Report, the Company’s Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2012, June 30, 2012 and September 30, 2012 and the other documents filed by the Company with the SEC since February 28, 2012.

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
Number

  

Description

99.1    Selected financial data.
99.2    Unaudited statements of comprehensive income.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

CME Group Inc.
By:  

/s/ Kathleen M. Cronin

  Kathleen M. Cronin
 

Senior Managing Director, General Counsel
and Corporate Secretary

 

Date: December 6, 2012


EXHIBIT INDEX

 

Exhibit
Number

  

Description

99.1    Selected financial data.
99.2    Unaudited statements of comprehensive income.
EX-99.1 2 d449371dex991.htm SELECTED FINANCIAL DATA. Selected financial data.

Exhibit 99.1

The income statement data and balance sheet data of CME Group Inc. (the company) presented in the following selected financial data in this Exhibit 99.1 is the same as the income statement data and balance sheet data presented in Item 6 of the company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011 filed with the Securities and Exchange Commission (SEC) on February 28, 2012 (the 2011 Annual Report), except that the per share data included in the following selected financial data has been modified to reflect on a retrospective basis the five-for-one split of the company’s Class A common stock effected by way of a stock dividend to the company’s Class A and Class B shareholders effective July 20, 2012, and except that the following selected financial data includes, for each of the periods shown, the weighted average number of common shares, which reflects such stock split on a retrospective basis. The following selected financial data should be read in conjunction with the other information in the company’s Current Report on Form 8-K of which this Exhibit 99.1 is a part and the information in the 2011 Annual Report, the company’s Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2012, June 30, 2012 and September 30, 2012 and the other documents filed by the company with the SEC since February 28, 2012.

SELECTED FINANCIAL DATA

 

     Year Ended or At December 31  

(dollars in millions, except per share data; shares in thousands)

   2011     2010     2009     2008     2007  

Income Statement Data:

          

Total revenues

   $ 3,280.6      $ 3,003.7      $ 2,612.8      $ 2,561.0      $ 1,756.1   

Operating income

     2,021.1        1,831.1        1,589.1        1,582.2        1,051.9   

Non-operating income (expense)

     (84.6     (109.2     (151.6     (334.2     43.9   

Income before income taxes

     1,936.5        1,721.9        1,437.5        1,248.0        1,095.8   

Net income attributable to CME Group

     1,812.3        951.4        825.8        715.5        658.5   

Earnings per common share attributable to CME Group:

          

Basic

   $ 5.45      $ 2.87      $ 2.49      $ 2.44      $ 3.01   

Diluted

     5.43        2.86        2.48        2.43        2.99   

Cash dividends per share

     1.12        0.92        0.92        1.92        0.69   

Weighted average number of common shares:

          

Basic

     332,737        331,493        331,828        293,689        218,770   

Diluted

     333,811        332,475        332,739        294,836        220,535   

Balance Sheet Data:

          

Total assets

   $ 40,758.7      $ 35,046.1      $ 35,651.0      $ 48,158.7      $ 20,306.2   

Short-term debt

     —          420.5        299.8        249.9        164.4   

Long-term debt

     2,106.8        2,104.8        2,014.7        2,966.1        —     

Shareholders’ equity

     21,552.0        20,060.1        19,301.0        18,688.6        12,305.6   
EX-99.2 3 d449371dex992.htm UNAUDITED STATEMENTS OF COMPREHENSIVE INCOME. Unaudited statements of comprehensive income.

Exhibit 99.2

This Exhibit 99.2 and the following unaudited consolidated statements of comprehensive income of CME Group Inc. (the company) and its subsidiaries should be read in conjunction with the other information in the company’s Current Report on Form 8-K of which this Exhibit 99.2 is a part and the information in the company’s Annual Report on Form 10-K for the year ended December 31, 2011 filed with the Securities and Exchange Commission (SEC) on February 28, 2012, the company’s Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2012, June 30, 2012 and September 30, 2012 and the other documents filed by the company with the SEC since February 28, 2012.

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions)

 

     Year Ended December 31,  
     2011     2010     2009  

Net income

   $ 1,814.4      $ 952.1      $ 825.8   

Other comprehensive income, net of tax:

      

Investment securities:

      

Net unrealized holding gains arising during the period

     166.4        10.1        19.5   

Reclassification adjustment for (gains) losses included in net income

     —          (1.2     22.4   

Income tax expense

     (23.7     (3.6     (16.5
  

 

 

   

 

 

   

 

 

 

Investment securities, net

     142.7        5.3        25.4   

Defined benefit plans:

      

Net change in defined benefit plans arising during the period

     (19.1     7.5        (5.0

Amortization of net actuarial losses included in pension expense

     1.7        2.1        2.7   

Income tax benefit (expense)

     6.5        (3.8     0.9   
  

 

 

   

 

 

   

 

 

 

Defined benefit plans, net

     (10.9     5.8        (1.4

Derivative instruments:

      

Net unrealized holding losses arising during the period

     —          (9.7     (8.8

Ineffectiveness on cash flow hedge

     0.1        8.6        —     

Amortization of effective portion of loss on cash flow hedges

     0.8        20.0        21.0   

Income tax expense

     (0.3     (7.4     (4.7
  

 

 

   

 

 

   

 

 

 

Derivative instruments, net

     0.6        11.5        7.5   

Foreign currency translation:

      

Foreign currency translation adjustments

     96.6        (0.9     4.3   

Income tax benefit (expense)

     (13.3     0.4        (1.7
  

 

 

   

 

 

   

 

 

 

Foreign currency translation, net

     83.3        (0.5     2.6   
  

 

 

   

 

 

   

 

 

 

Other comprehensive income, net of tax

     215.7        22.1        34.1   
  

 

 

   

 

 

   

 

 

 

Comprehensive income

     2,030.1        974.2        859.9   

Less: comprehensive income attributable to redeemable non-controlling interest

     2.1        0.7        —     
  

 

 

   

 

 

   

 

 

 

Comprehensive income attributable to CME Group

   $ 2,028.0      $ 973.5      $ 859.9